Pharmaceutical

F. Hoffmann-La Roche gets grant for system for identifying nucleic acid bases using nanopore technology

Discover how F. Hoffmann-La Roche's patented system uses nanopores to identify nucleic acid bases, increasing confidence in base identification. Explore the innovative approach in genomics and personalized medicine.

Apr 5, 2024 - 00:00
Discover how F. Hoffmann-La Roche's patented system uses nanopores to identify nucleic acid bases, increasing confidence in base identification. Explore the innovative approach in genomics and personalized medicine.
Read the original article

Tags:

Previous Article

Chiesi Farmaceutici gets grant for pharmaceutical formulation for intraduodenal ...

Next Article

Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: In the U.S., scientists see barriers to the development of CAR-T cell therapies. In Spain, a hospital brews its own

STAT+: In the U.S., scientists see barriers to the deve...

Dec 19, 2023

Roche relaunches refillable wet AMD implant two years after recall

Roche relaunches refillable wet AMD implant two years a...

Jul 10, 2024

FDA launches new rare disease innovation hub

FDA launches new rare disease innovation hub

Jul 20, 2024